Dr. Kamal Moulana, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1240 Woodland Dr, Elizabethtown, KY 42701 Phone: 270-769-9881 Fax: 270-769-9589 |
Mr. Aijaz A Yazdani, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 914 N Dixie Ave, Suite 102, Elizabethtown, KY 42701 Phone: 270-735-9066 Fax: 270-735-9036 |
David Dao, Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1234 Woodland Dr, Elizabethtown, KY 42701 Phone: 270-769-1371 |
Aaron Michael Mulhall, Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 110 Layman Ln, Elizabethtown, KY 42701 Phone: 270-706-5787 Fax: 270-706-5788 |
Mr. William Benjamin Cundiff, D.O Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 110 Layman Ln, Elizabethtown, KY 42701 Phone: 270-706-5787 Fax: 270-706-5788 |
News Archive
TenX Biopharma, Inc. announced today it has signed a licensing agreement to acquire exclusive worldwide rights to develop and commercialize zanolimumab (HuMax-CD4®) from Genmab A/S.
Irritable bowel syndrome makes life miserable for those affected an estimated ten percent or more of the population. And what irritates many of them even more is that they often are labeled as hypochondriacs, since physical causes for irritable bowel syndrome have never been identified. Now, biologists at the Technische Universitaet Muenchen (TUM) have shed new light on the matter: They have discovered mini-inflammations in the mucosa of the gut, which upset the sensitive balance of the bowel and are accompanied by sensitization of the enteric nervous system.
Sodexo, world leader in Quality of Daily Life solutions, was ranked #2 on the 2011 DiversityInc Top 50 Companies for Diversity list, affirming its position as a benchmark employer in leveraging diversity and inclusion expertise as a competitive advantage in business. This year 535 companies applied to be evaluated by DiversityInc.
Today in Canberra, Tony Abbott has let slip a historic opportunity for health reform. Today the state and federal health ministers met and had Professor John Dwyer and some of the finest minds in health give them health reform proposals.
Regeneron Pharmaceuticals, Inc. today announced that the Company has entered into a non-exclusive license and partial settlement agreement with Genentech, Inc., a member of the Roche Group relating to U.S. ophthalmic sales of EYLEA (aflibercept) Injection.
› Verified 7 days ago